Cat.#: ACPP-1119
| Despition | CD56 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1356 | GIRK2 Blocking Peptide (AC1356) | 250 µg | inquiry |
| ACPP-1618 | Human SYT11 Protein (AC1618) | 2 µg | inquiry |
| ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
| ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg | inquiry |
| ACPP-1389 | AHSG (AC1389) | 10 µg | inquiry |
| ACPP-1806 | Human SCGN Protein (AC1806) | 2 µg | inquiry |
| ACPP-1167 | Recombinant Human CD133 Protein (Fc Tag) (AC1167) | 50 µg | inquiry |
| ACPP-1006 | Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) | 50 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.